Free Trial

J&J Effectiveness Headline Spurs Quick Gap Bid Off Lows

US TSY FUTURES

Tsys jumped off lows after J&J headline annc Covid vaccine effectiveness at 66% in global clinical trial effectiveness. Equities that had been climbing off lows slip again (ESH1 -43.5). Yield curves still steeper, near early month highs.

  • 3M10Y +1.885, 99.956 (L: 97.139 / H: 101.742)
  • 2Y10Y +2.081, 94.635 (L: 91.875 / H: 96.168)
  • 2Y30Y +2.299, 170.647 (L: 167.234 / H: 172.758)
  • 5Y30Y +1.786, 139.364 (L: 136.831 / H: 140.753)
  • Current futures levels:
  • Mar 2Y up 0.25/32 at 110-15.625 (L: 110-15.25 / H: 110-15.875)
  • Mar 5Y up 0.25/32 at 125-30 (L: 125-28.25 / H: 125-31)
  • Mar 10Y down 2/32 at 137-6 (L: 137-02 / H: 137-10.5)
  • Mar 30Y down 9/32 at 169-9 (L: 168-28 / H: 169-29)
  • Mar Ultra 30Y down 11/32 at 205-27 (L: 204-31 / H: 207-00)

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.